69 related articles for article (PubMed ID: 22204965)
1. The RhoA GTPase-activating protein DLC2 modulates RhoA activity and hyperalgesia to noxious thermal and inflammatory stimuli.
Chan FK; Chung SS; Ng IO; Chung SK
Neurosignals; 2012; 20(2):112-26. PubMed ID: 22204965
[TBL] [Abstract][Full Text] [Related]
2. Role of DLC2 and RhoA/ROCK pathway in formalin induced inflammatory pain in mice.
Wong SSC; Lee UM; Wang XM; Chung SK; Cheung CW
Neurosci Lett; 2019 Sep; 709():134379. PubMed ID: 31323253
[TBL] [Abstract][Full Text] [Related]
3. Deleted in liver cancer 2 (DLC2) suppresses cell transformation by means of inhibition of RhoA activity.
Leung TH; Ching YP; Yam JW; Wong CM; Yau TO; Jin DY; Ng IO
Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15207-12. PubMed ID: 16217026
[TBL] [Abstract][Full Text] [Related]
4. Reduced inflammatory and neuropathic pain and decreased spinal microglial response in fractalkine receptor (CX3CR1) knockout mice.
Staniland AA; Clark AK; Wodarski R; Sasso O; Maione F; D'Acquisto F; Malcangio M
J Neurochem; 2010 Aug; 114(4):1143-57. PubMed ID: 20524966
[TBL] [Abstract][Full Text] [Related]
5. DLC2 modulates angiogenic responses in vascular endothelial cells by regulating cell attachment and migration.
Lin Y; Chen NT; Shih YP; Liao YC; Xue L; Lo SH
Oncogene; 2010 May; 29(20):3010-6. PubMed ID: 20208559
[TBL] [Abstract][Full Text] [Related]
6. FKBP51 regulates cell motility and invasion via RhoA signaling.
Takaoka M; Ito S; Miki Y; Nakanishi A
Cancer Sci; 2017 Mar; 108(3):380-389. PubMed ID: 28032931
[TBL] [Abstract][Full Text] [Related]
7. Deleted in liver cancer (DLC) 2 encodes a RhoGAP protein with growth suppressor function and is underexpressed in hepatocellular carcinoma.
Ching YP; Wong CM; Chan SF; Leung TH; Ng DC; Jin DY; Ng IO
J Biol Chem; 2003 Mar; 278(12):10824-30. PubMed ID: 12531887
[TBL] [Abstract][Full Text] [Related]
8. Underexpression of deleted in liver cancer 2 (DLC2) is associated with overexpression of RhoA and poor prognosis in hepatocellular carcinoma.
Xiaorong L; Wei W; Liyuan Q; Kaiyan Y
BMC Cancer; 2008 Jul; 8():205. PubMed ID: 18651974
[TBL] [Abstract][Full Text] [Related]
9. The protein kinase IKKε is a potential target for the treatment of inflammatory hyperalgesia.
Möser CV; Kynast K; Baatz K; Russe OQ; Ferreirós N; Costiuk H; Lu R; Schmidtko A; Tegeder I; Geisslinger G; Niederberger E
J Immunol; 2011 Sep; 187(5):2617-25. PubMed ID: 21813779
[TBL] [Abstract][Full Text] [Related]
10. RhoA/Rho kinase pathway contributes to the pathogenesis of thermal hyperalgesia in diabetic mice.
Ohsawa M; Aasato M; Hayashi SS; Kamei J
Pain; 2011 Jan; 152(1):114-122. PubMed ID: 20980102
[TBL] [Abstract][Full Text] [Related]
11. Impaired nocifensive behaviours and mechanical hyperalgesia, but enhanced thermal allodynia in pituitary adenylate cyclase-activating polypeptide deficient mice.
Sándor K; Kormos V; Botz B; Imreh A; Bölcskei K; Gaszner B; Markovics A; Szolcsányi J; Shintani N; Hashimoto H; Baba A; Reglodi D; Helyes Z
Neuropeptides; 2010 Oct; 44(5):363-71. PubMed ID: 20621353
[TBL] [Abstract][Full Text] [Related]
12. Differential involvement of the integrin-linked kinase (ILK) in RhoA-dependent rearrangement of F-actin fibers and induction of connective tissue growth factor (CTGF).
Graness A; Giehl K; Goppelt-Struebe M
Cell Signal; 2006 Apr; 18(4):433-40. PubMed ID: 15970428
[TBL] [Abstract][Full Text] [Related]
13. Deleted in liver cancer 1 controls cell migration through a Dia1-dependent signaling pathway.
Holeiter G; Heering J; Erlmann P; Schmid S; Jähne R; Olayioye MA
Cancer Res; 2008 Nov; 68(21):8743-51. PubMed ID: 18974116
[TBL] [Abstract][Full Text] [Related]
14. Receptor tyrosine kinase activation of RhoA is mediated by AKT phosphorylation of DLC1.
Tripathi BK; Grant T; Qian X; Zhou M; Mertins P; Wang D; Papageorge AG; Tarasov SG; Hunter KW; Carr SA; Lowy DR
J Cell Biol; 2017 Dec; 216(12):4255-4270. PubMed ID: 29114068
[TBL] [Abstract][Full Text] [Related]
15. Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma.
Wong CM; Yam JW; Ching YP; Yau TO; Leung TH; Jin DY; Ng IO
Cancer Res; 2005 Oct; 65(19):8861-8. PubMed ID: 16204057
[TBL] [Abstract][Full Text] [Related]
16. Thrombin receptor: An endogenous inhibitor of inflammatory pain, activating opioid pathways.
Martin L; Augé C; Boué J; Buresi MC; Chapman K; Asfaha S; Andrade-Gordon P; Steinhoff M; Cenac N; Dietrich G; Vergnolle N
Pain; 2009 Nov; 146(1-2):121-9. PubMed ID: 19674841
[TBL] [Abstract][Full Text] [Related]
17. Deleted in Liver Cancer 2 (DLC2) protein expression in hepatocellular carcinoma.
Wolosz D; Walczak A; Szparecki G; Dwojak M; Winiarska M; Wolinska E; Gornicka B
Eur J Histochem; 2019 Feb; 63(1):. PubMed ID: 30827083
[TBL] [Abstract][Full Text] [Related]
18. The beta-amyloid protein of Alzheimer's disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism.
Petratos S; Li QX; George AJ; Hou X; Kerr ML; Unabia SE; Hatzinisiriou I; Maksel D; Aguilar MI; Small DH
Brain; 2008 Jan; 131(Pt 1):90-108. PubMed ID: 18000012
[TBL] [Abstract][Full Text] [Related]
19. Flavone inhibits migration through DLC1/RhoA pathway by decreasing ROS generation in breast cancer cells.
Zhu W; Ma L; Yang B; Zheng Z; Chai R; Liu T; Liu Z; Song T; Li F; Li G
In Vitro Cell Dev Biol Anim; 2016 May; 52(5):589-97. PubMed ID: 26935193
[TBL] [Abstract][Full Text] [Related]
20. Essential role of the synaptic vesicle protein synapsin II in formalin-induced hyperalgesia and glutamate release in the spinal cord.
Schmidtko A; Del Turco D; Coste O; Ehnert C; Niederberger E; Ruth P; Deller T; Geisslinger G; Tegeder I
Pain; 2005 May; 115(1-2):171-81. PubMed ID: 15836980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
